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Abstract A series of Schiff bases (1-16) and esters (17-27) of p-amino 
benzoic acid (PABA) was synthesized and its in vitro antimicrobial potential 
was evaluated by using tube dilution method. Compound 11 was found to be 
most promising antibacterial agent (pMIC
bs
 = 2.11 µM/ml) having antibacterial 
potential comparable to standard drug norfloxacin (pMIC
bs
 = 2.61 µM/ml) and 
may be taken as a lead compound for the development of novel antibacterial 
agents. QSAR analysis indicated that electronic parameters, total energy (Te) 
and energy of lowest unoccupied molecular orbital (LUMO) were found 
dominant in explaining the antimicrobial activity of synthesized compounds.
Keywords: PABA; Synthesis; Antimicrobial; mt-QSAR; LOO method 
1. INTRODUCTION
The emerging problem of resistance to conventional antimicrobial agents has stimulated interest in the development of new antimicrobials. Newly characterized molecules have inspired molecular designs for the 
creation of therapeutics, and will continue to do so as more are discovered, 
because these are based on antimicrobial strategies that have proven efficacious 
over millennia (Zasloff, 2002).
p-Aminobenzoic acid (PABA) is a cyclic amino acid and belongs to the 
vitamin B group and used as a protective drug against UV irradiation and in 
diagnostic tests for gastrointestinal tract. PABA is also having anti-virulent 
properties and therapeutic effect against typhoid and rickettsial diseases 
(Akberova et al, 2002). Schiff bases show various biological properties 
including antibacterial, antifungal antitumor, analgesic and anti-inflammatory 
activity (Chhonker et al, 2009).
Quantitative structure activity relationship (QSAR) studies provide 
medicinal chemists valuable information that is useful for drug design and 





construct a relationship between chemical structures and their biological 
activities as a linear regression model (Sabet et al, 2010).
So, in the present study, we hereby report the synthesis, antimicrobial 
evaluation and QSAR studies of PABA derivatives.
2. MATERIALS AND METHODS
2.1Materials and Instruments used
Starting materials were obtained from M/s. Himdea Chemicals Pvt. Ltd. and 
were used without further purification. Reaction progress was observed by thin 
layer chromatography making use of commercial silica gel plates (Merck), Silica 
gel F254 on aluminum sheets. Melting points were determined in open capillary 
tubes on a Sonar melting point apparatus. 1H nuclear magnetic resonance 
(1H NMR) spectra were determined by AV 300 spectrometer in appropriate 
deuteriated solvents and were expressed in parts per million (δ, ppm) downfield 
from tetramethylsilane (internal standard) NMR data are given as multiplicity (s, 
singlet; d, doublet; t, triplet; m, multiplet) and number of protons. Infrared (IR) 
spectra were recorded on a Schimazdu 8400S FTIR spectrometer. Elemental 
analysis was performed on a Perkin–Elmer 2400 C, H, N analyzer.
2.2 General procedure for the synthesis of Schiff’s bases of PABA (1-16)
p-Amino benzoic acid (0.01 mol) and benzaldehyde (0.01 mol) were refluxed 
in ethanol for 3-4 h and the contents were then poured on crushed ice. The 
precipitated crude product was filtered, dried and recrystallized from ethanol. 
The later (0.08 mol) was refluxed with ethanol (0.74 mol) in presence of 
sulphuric acid for 3-4 h. The reaction mixture was then added to 200 ml ice cold 
water, neutralized with sodium bicarbonate solution followed by the extraction 
of ester with ether (50 ml). The ether layer was separated which on evaporation 
yielded the ethyl ester of PABA. The synthesized ester (0.01mol) was treated 
with hydrazine hydrate (0.02mol) in presence of ethanol and refluxed for 2-3 
h. The reaction mixture was then cooled and resultant precipitate was filtered 
off and recrystallized from ethanol. Finally, a mixture of above synthesized 
hydrazide (0.1mol) and corresponding aromatic aldehyde (0.1mol) in ethanol 
was refluxed in presence of catalytic amount of glacial acetic acid for 2-3 h. 
The mixture was then cooled and poured in ice cold water. The Schiff’s base 
obtained was filtered and recrystallized from ethanol.
2.3 General procedure for the synthesis of esters of PABA (17-27)
A mi.xture of p-amino benzoic acid (0.08 mol) and corresponding alcohol 








Then the reaction mixture was added to 200 ml ice cold water, neutralized 
with sodium bicarbonate solution followed by the extraction of ester with ether 
(50 ml). The ether layer was separated which on evaporation yielded the ester 
derivatives of PABA.
Compound 1: Yield – 77.47%; m.p. – 100-102; IR (KBr pellets, cm-1): 1533 
(C=C str., phenyl nucleus), 3001 (C-H str., phenyl nucleus), 1665 (C=N str. 




-Cl), 3406 (N-H str., sec-amide), 1072 (N-N str., 
-NHN=CH) ; 1H NMR (DMSO): 7.316-8.013 (m, 13H, ArH), 8.650 (s, 1H, 






O: C, 69.71; H, 
4.46; N, 11.61; Found: C, 69.80; H, 4.51; N, 11.64
Compound 11: Yield – 70.58%; m.p. – 110-112; IR (KBr pellets, cm-1) 1530 
(C=C str., phenyl nucleus), 3001 (C-H str., phenyl nucleus), 1650 (C=N str. 




-Br), 1680 (C=O str., sec-amide), 1066 (N-N 
str., -NHN=CH); 1H NMR (DMSO) 7.460-7.986 (m, 13H, ArH), 8.015 (s, 1H, 










O C, 62.08; 
H, 3.97; N, 10.34; Found: C, 61.97; H, 4.00; N, 10.38
Compound 13: Yield – 61.06 %; m.p. – 155-157; Yield – 77.47%; m.p. – 100-
102; IR (KBr pellets, cm-1) 3039 (C-H str., phenyl nucleus), 1716 (C=N str. 
–N=CH), 3415 (N-H str., sec-amide), 956 (N-N str., -NHN=CH), 2951 (C-H 
str., alkene); 1H NMR (DMSO) 7.116-7.835 (m, 14H, ArH), 8.383 (s, 1H, 






O: C, 78.16; H, 
5.42; N, 11.89; Found: C, 78.12; H, 5.49; N, 11.84
Compound 20: Yield – 87.90%; m.p. – 110-112; IR (KBr pellets, cm-1) 1546 
(C=C str., phenyl nucleus), 2933 (C-H str., phenyl nucleus), 1604 (N-H in plane 
bending, 10 amine), 1820 (C=O str., ester), 2933 (CH
3
 asym. str., alkane); 1H 
NMR (DMSO) 6.394-7.588 (m, 4H, ArH), 1.130 (t, 3H, CO -CH
2
-), 5.016 (m, 
2H, -CH
3






: C, 65.44; H, 6.71; N, 8.48; Found; 
C, 65.39; H, 6.76; N, 8.43
2.4 Evaluation of antimicrobial activity (Determination of MIC) 
The antimicrobial activity was performed against Gram-positive bacteria: 
Staphylcococcus aureus MTCC 2901, Bacillus sublitis MTCC 2063, Gram-
negative bacterium: Escherichia coli MTCC 1652 and fungal strains: Candida 
albicans MTCC 227 and Aspergillus niger MTCC 8189 using tube dilution 
method (Cappucino and Sherman, 1999). Dilutions of test and standard 
compounds were prepared in double strength nutrient broth – I.P. (bacteria) 
or Sabouraud dextrose broth I.P. (fungi) (Pharmacopoeia of India, 2007). The 





and at 37 °C for 48 h (C. albicans) and the results were recorded in terms of 
MIC.
2.5 QSAR studies
The structures of PABA derivatives were first pre-optimized with the 
Molecular Mechanics Force Field (MM+) procedure included in Hyperchem 
6.03 (1993) and the resulting geometries were further refined by means of 
the semiempirical method PM3 (Parametric Method-3). We chose a gradient 
norm limit of 0.01 kcal/A˚ for the geometry optimization. The lowest energy 
structure was used for each molecule to calculate physicochemical properties 
using TSAR 3.3 software for Windows (2000). Further, the regression analysis 
was performed using the SPSS software package (1999).
3. RESULTS AND DISSCUSSION
3.1 Chemistry
Schiff bases (1-16) and esters (17-27) of PABA were synthesized using the 
synthetic procedures outlined in Scheme 1. Esters were synthesized by reaction 
of PABA with different alcohols in the presence of sulphuric acid. In order to 
synthesize Schiff bases of PABA, firstly p-amino benzoic acid was coupled with 
benzaldehyde in order to block amino group of PABA. The later was reacted with 
ethanol to synthesize ethyl 4-(benzylideneamino)benzoate. 4-(benzylideneamino)
Scheme1: Synthetic scheme for the synthesis of Schiff bases (1-16) and 








Table 1: The physicochemical properties of PABA derivatives (1-27).
S. 
NO.



























417.46 180-182 0.46 67.62








355.39 220-222 0.67 68.54






O 361.82 103-105 0.50 63.95






O 406.28 102-104 0.78 92.00










O 370.45 80-82 0.30* 57.96





















387.43 155-157 0.74* 91.75























387.43 135-137 0.62* 76.28






O 406.28 110-112 0.54 70.58
12. H NO
2








372.38 95-97 0.56 93.02






O 353.42 115-117 0.67 61.06
14. H OCH
3








373.40 175-177 0.78 57.92
15. OCH
3








357.41 92-94 0.83 73.33






O 361.82 180-182 0.71 78.43
*Chloroform:Toluene = 7:3
benzohydrazide was synthesized by reaction of ethyl 4-(benzylideneamino)
benzoate with hydrazine hydrate which on reaction with corresponding aldehydes 
yielded Schiff bases of p-amino benzoic acid. The synthesized compounds were 
characterised by physicochemical as well as spectral means. The elemental 
analysis results were within ± 0.4% of the theoretical values. Physicochemical 
properties of synthesized compounds are given in Table 1. 
3.2 Antimicrobial activity
The results of antimicrobial activity of synthesized compounds are presented in 


















































































227.26 140-142 0.78 87.45
**Hexane:Acetone = 1:1
activity as compared to antifungal activity. In case of antimicrobial activity against 
S. aureus, compound 2, N’-(3,4,5-trimethoxy benzylidene)-4-(benzylidene 
amino) benzohydrazide with pMIC
sa 
value 1.82 µM/ml was found to be most potent 
among the synthesized PABA derivatives. The antimicrobial activity against B. 
subtilis suggested that compound 11, N’-(3-bromo benzylidene)-4-(benzylidene 
amino)benzohydrazide (pMIC
bs 
= 2.11µM/ml) was found most potent among 
the synthesized compounds. In case of E. coli, compound 14, N’-(3-methoxy-
4-hydroxy benzylidene)-4-(benzylidene amino)benzohydrazide (pMIC
ec
=1.78 
µM/ml) was found better antibacterial agent among the synthesized series. The 
antifungal activity results showed that compound 5, N’-(4-bromo benzylidene)-
4-(benzylidene amino)benzohydrazide was found to be most potent than the 
other members of the series against both fungal strains tested i.e. A. niger as well 
as C. albicans (pMIC
an, ca
=1.81 µM/ml). 
3.3 Structure Activity Relationship (SAR) studies
From the antimicrobial activity results of PABA derivatives, the following 
structure activity relationship may be concluded:
1 In general, Schiff’s bases of PABA were found to be more potent than its 
esters.
2 Electron withdrawing group (bromo) increased antimicrobial activity of the 
synthesized compounds against B. subtilis, C. albicans and A. niger. m-Bromo 
derivative (11) was found to be active against B. subtilis while p-bromo 








Table 2. Antimicrobial activity (pMIC in µM/ml) of PABA derivatives (1-27).
Comp. pMICsa pMICbs pMICec pMICca pMICan pMICab pMICaf pMICam
1 1.16 1.46 1.46 1.46 1.16 1.36 1.31 1.34
2 1.82 1.52 1.22 1.52 1.22 1.52 1.37 1.46
3 1.45 1.45 1.45 1.45 1.15 1.45 1.30 1.39
4 0.86 1.16 1.46 1.76 1.46 1.16 1.61 1.34
5 1.81 0.91 1.21 1.81 1.81 1.31 1.81 1.51
6 1.47 1.77 1.17 1.77 1.17 1.47 1.47 1.47
7 1.44 1.74 1.14 1.74 1.74 1.44 1.74 1.56
8 1.49 1.79 1.19 1.79 1.49 1.49 1.64 1.55
9 1.46 1.46 1.16 1.76 1.46 1.36 1.61 1.46
10 1.49 1.49 1.49 1.79 1.49 1.49 1.64 1.55
11 1.51 2.11 1.21 1.51 1.51 1.61 1.51 1.57
12 1.47 2.08 1.17 1.47 1.78 1.57 1.62 1.59
13 0.85 1.45 1.15 1.75 1.45 1.15 1.60 1.33
14 1.48 2.08 1.78 1.78 1.78 1.78 1.78 1.78
15 1.46 1.46 1.46 1.76 1.76 1.46 1.76 1.58
16 1.46 1.46 1.76 1.76 1.76 1.56 1.76 1.64
17 1.19 1.19 0.89 1.49 1.49 1.09 1.49 1.25
18 1.19 1.19 1.19 1.49 1.19 1.19 1.34 1.25
19 1.49 1.19 0.89 1.49 1.49 1.19 1.49 1.31
20 1.42 1.12 0.82 1.42 1.42 1.12 1.42 1.24
21 1.46 1.16 0.86 1.16 1.46 1.16 1.31 1.22
22 1.16 1.16 0.86 1.46 1.16 1.06 1.31 1.16
23 1.22 1.22 1.22 1.52 0.92 1.22 1.22 1.22
24 1.22 1.22 1.22 1.22 1.52 1.22 1.37 1.28
25 1.30 1.30 1.60 1.30 1.30 1.40 1.30 1.36
26 1.24 1.24 1.24 1.24 1.55 1.24 1.39 1.30
27 1.26 1.26 1.26 1.56 1.26 1.26 1.41 1.32
SD 0.22 0.32 0.26 0.20 0.24 0.18 0.18 0.16






3 Presence of electron donating groups (methoxy and hydroxyl) improved 
the antimicrobial activity of PABA derivatives against S. aureus and E. 
coli. 3,4,5-Trimethoxy derivative (2) was found to be active against S. 
aureus and 3-methoxy-4-hydroxyl derivative (14) was found to be active 
against E. coli. 
4 Presence of an additional conjugation (13) decreased antibacterial activity 
of the synthesized compounds.
5 By analysing the structure of most active compounds, it was evidenced 
that different structural requirements were necessary for a compound to be 
active against different microbial species. These results were similar to the 
findings of Sortino et al. (2007).
The findings of antimicrobial study are presented in Figure 1.
Figure 1: Structural requirements for the antimicrobial activity of Schiff bases 
and esters of PABA. SAR for antimicrobial activity of PABA derivatives
3.4 QSAR Studies
Quantitative structure activity relationship (QSAR) studies were performed 
using linear free energy relationship (LFER) model described by Hansch 
and Fujita (1964). In the present study, a dataset of 27 derivatives of 
PABA derivatives (1-27) was used for linear regression model generation. 









Biological activity i.e. pMIC values (i.e. –log MIC) were used as dependent 
variables. Different molecular descriptors (independent variables) selected 
for the present study are listed in Table 3. The values of selected molecular 
descriptors used in the QSAR study are presented in Table 4.
mt-QSAR model is a single equation that considered the nature of molecular 
descriptors which were common and essential for describing the antibacterial 
and antifungal activity (Gonzalez-Diaz et al, 2007, 2008; Gonzalez-Diaz and 
Prado-Prado, 2008). 
In the present study, we attempted to develop three different types of mt-
QSAR models viz. mt-QSAR model to describe antibacterial, antifungal and 
antimicrobial activity of the synthesized compounds. 
Table 3: QSAR descriptors used in the study
S. No. QSAR descriptor Type
1 log P Lipophilic
2 Zero order molecular connectivity index (0χ) Topological
3 First order molecular connectivity index (1χ) Topological
4 Second order molecular connectivity index (2χ) Topological
5 Valence zero order molecular connectivity index (0χv) Topological
6 Valence first order molecular connectivity index (1χv) Topological
7 Valence second order molecular connectivity index (2χv) Topological
8 Kier’s alpha first order shape index (κα
1
) Topological
9 Kier’s alpha second order shape index (κα
2
) Topological
10 Kier’s first order shape index (κ
1
) Topological
11 Randic topological index Topological
12 Balaban topological index Topological
13 Wiener’s topological index Topological
14 Kier’s second order shape index (κ
2
) Topological
15 Ionization potential Electronic
16 Dipole moment (µ) Electronic
17 Energy of highest occupied molecular orbital (HOMO) Electronic




Nuclear Energy (Nu. E)
Electronic
Electronic





Compounds 1, 2, 3, 6 and 23 were removed as outliers and were not involved 
in the data set for QSAR model generation according to recommendations of 
Furusjo et al (Furusjo et al, 2006).
The average antibacterial activity values were correlated with the 
molecular descriptors of synthesized compounds (Table 5). In general, high 
Table 4: Values of selected descriptors calculated for QSAR studies.
Comp. log P MR 0χ 0χv κ1 κ2 J Te LUMO HOMO µ
1 5.72 105.87 18.19 14.66 20.73 11.11 1.16 -4220.83 -0.80 -9.06 2.86
2 4.44 120.46 22.05 17.53 25.62 13.65 1.22 -5288.06 -0.87 -8.75 2.89
3 4.88 107.66 18.90 14.45 21.70 11.87 1.17 -4308.97 -0.96 -9.12 1.84
4 5.72 105.87 18.19 14.66 20.73 11.11 1.19 -4220.73 -0.74 -9.04 3.65
5 5.99 108.69 18.19 15.46 20.73 11.11 1.17 -4200.34 -0.85 -9.05 2.45
6 4.99 114.78 19.77 15.91 22.68 12.00 1.17 -4392.42 -0.72 -8.16 5.59
7 5.67 106.11 18.19 14.46 20.73 11.11 1.17 -4016.61 -0.77 -8.82 3.99
8 4.70 113.99 20.48 16.20 23.66 12.76 1.18 -4812.31 -0.79 -8.49 3.11
9 4.95 107.53 18.90 14.87 21.70 11.87 1.17 -4336.62 -0.77 -8.66 3.89
10 5.01 113.97 20.48 15.95 23.66 12.76 1.17 -4812.97 -0.76 -8.56 2.85
11 5.99 108.69 18.19 15.46 20.73 11.11 1.16 -4200.33 -0.81 -9.06 2.87
12 5.15 108.39 19.77 14.73 22.68 12.00 1.16 -4691.56 -1.15 -9.39 8.60
13 5.61 111.31 18.74 14.70 21.70 12.54 1.13 -4143.91 -0.79 -8.70 3.55
14 4.66 109.22 19.77 15.24 22.68 12.00 1.17 -4657.19 -0.76 -8.57 0.42
15 4.95 107.53 18.90 14.87 21.70 11.87 1.20 -4336.46 -0.71 -8.96 4.79
16 5.72 105.87 18.19 14.66 20.73 11.11 1.17 -4220.85 -0.83 -9.00 2.43
17 2.20 56.16 10.39 8.32 12.07 6.48 2.00 -2463.60 -0.02 -8.65 4.21
18 2.22 55.98 10.55 8.49 12.07 5.78 2.12 -2463.47 -0.13 -8.82 3.40
19 2.21 56.03 10.55 8.49 12.07 5.78 2.06 -2463.48 -0.16 -8.84 3.86
20 1.34 47.03 8.97 6.91 10.08 4.89 2.05 -2151.94 -0.02 -8.65 4.24
21 1.80 51.56 9.68 7.62 11.08 5.67 2.03 -2307.77 -0.02 -8.65 4.14
22 1.75 51.45 9.84 7.78 11.08 5.02 2.10 -2307.66 -0.13 -8.82 3.46
23 2.60 60.76 11.10 9.03 13.07 7.30 1.97 -2619.43 -0.02 -8.65 4.13
24 2.53 60.71 11.26 9.19 13.07 6.55 2.02 -2619.34 -0.15 -8.83 3.60
25 3.79 74.56 13.22 11.15 16.06 9.87 1.88 -3086.94 -0.02 -8.65 4.19
26 2.58 63.30 11.38 9.32 12.46 6.07 1.56 -2747.58 -0.13 -8.82 3.41








colinearity (r > 0.5) was observed between different parameters. The high 
interrelationship was observed between topological parameters, zero order 
molecular connectivity index (0χ) and Kier’s first order shape index (κ
1
) (r 
= 0.998), and low interrelationship was observed for electronic parameters, 
dipole moment (µ) and energy of lowest unoccupied molecular orbital LUMO 
(r = -0.043). The correlation of antibacterial, antifungal and antimicrobial 
activities of the synthesized compounds with molecular descriptors is 
presented in Table 6.
Electronic parameter, total energy (Te) was found to be dominating 
descriptor for antibacterial activity of the synthesized compounds (Eq. 1). 
LR-mt-QSAR model for antibacterial activity 
 pMIC Te + 0.793ab =−0 000152.  (1)
 n r q s F= = = = =22 0 758 0 500 0 131 27 05
2. . . .  
Here and thereafter, n - number of data points, r - correlation coefficient, q2 - 
cross validated r2 obtained by leave one out method, s - standard error of the 
estimate and F - Fischer statistics.
The developed QSAR model for antibacterial activity (Eq. 1) indicated 
that there was a negative correlation between Te and antibacterial activity of 
the synthesized compounds. This was evidenced by least antibacterial activity 
compound 22 (pMIC
ab
 = 1.06 µM/ml) having highest Te value (-2307.66).
Table 5. Correlation matrix for the antibacterial activity of the synthesized 
PABA derivatives.
pMICab log P MR
0χ κ1 J W Te LUMO HOMO µ
pMICab 1.000
log P 0.644 1.000
MR 0.711 0.962 1.000
0χ 0.738 0.934 0.995 1.000
κ
1
0.738 0.931 0.992 0.998 1.000
J -0.675 -0.927 -0.959 -0.947 -0.933 1.000
W 0.716 0.908 0.985 0.995 0.993 -0.935 1.000
Te -0.758 -0.916 -0.986 -0.997 -0.995 0.940 -0.992 1.000
LUMO -0.677 -0.915 -0.949 -0.950 -0.940 0.920 -0.950 0.946 1.000
HOMO -0.142 -0.344 -0.205 -0.181 -0.161 0.252 -0.137 0.182 0.401 1.000





The developed QSAR model (Eq. 1) was cross validated by q2 value (q2 
= 0.500) obtained by leave one out (LOO) method which indicated that the 
model developed was a valid one. As the observed and predicted values were 
close to each other (Table 7), the mt-QSAR model for antibacterial activity 





(Fig. 2) also favoured the developed model 






indicated that there was
 
no systemic error in model development as 
the propagation of error was observed on both sides of zero (Kumar et al, 
2007).
Electronic parameter, energy of lowest unoccupied molecular orbital 
(LUMO) was found most important in expressing antifungal activity of the 
synthesized compounds (Table 6). So, QSAR model for antifungal activity 
(Eq. 2) was developed using LUMO.
LR-mt-QSAR model for antifungal activity 
 pMIC LUMO + 1.40af =−0 169.  (2)
 n r q s F= = = = =22 0 663 0 333 0 074 15 692. . . .  
As in case of antibacterial activity, antifungal activity of the synthesized 
compounds was also negatively correlated with their LUMO values (Tables 
2 and 4). 
According to the FMO concept, the HOMO and LUMO of a molecule 
play important roles in intermolecular interactions. Extending the concept to 
binding in drug-receptor systems, the major contribution to binding involves the 
interaction between the HOMO of the drug with the LUMO of the receptor and 
that between LUMO of the drug with the HOMO of the receptor. (Narasimhan 
et al, 2011).
The validity and predictability of the QSAR model for antifungal activity 
i.e. Eq. 2 was cross validated by q2 value (q2 = 0.333) obtained by leave one 
out (LOO) method. In case of Eq. 2, the value of q2 less than 0.5 indicated 
that the developed model was an invalid one. But one should not forget the 
recommendations of Golbraikh and Tropsha, who reported that the only way 
to estimate the true predictive power of a model was to test their ability to 
predict accurately the biological activities of compounds. As the observed and 
predicted values were close to each other (Table 7), the mt-QSAR model for 
antifungal activity Eq. (3) was found to be a valid one (Golbraikh and Tropsha, 
2002). 
Electronic parameter total energy (Te) was found to be most effective in 








Table 6: Correlation of antibacterial, antifungal and antimicrobial activities 







Cos E 0.690 0.627 0.731
log P 0.644 0.605 0.685
MR 0.711 0.607 0.742
0χ 0.738 0.606 0.764
0χv 0.730 0.603 0.757
1χ 0.725 0.608 0.755
1χv 0.724 0.602 0.752
2χ 0.732 0.622 0.764
2χv 0.720 0.624 0.754
3χ 0.691 0.565 0.715



















R 0.725 0.608 0.755
J -0.675 -0.621 -0.718
W 0.716 0.597 0.744
Te -0.758 -0.610 -0.783
Ee -0.750 -0.604 -0.774
Ne 0.748 0.604 0.773
SA 0.732 0.586 0.754
IP 0.142 0.359 0.211
LUMO -0.677 -0.663 -0.729
HOMO -0.142 -0.359 -0.211





Table 7: Observed, predicted and residual antimicrobial activities of the 
synthesized compounds obtained by mt-QSAR models.
Comp.
pMICab pMICaf pMICam
Obs. Pre. Res. Obs. Pre. Res. Obs. Pre. Res.
1 1.36 1.43 -.0.07 1.31 1.54 -0.23 1.34 1.47 -0.13
2 1.52 1.60 -0.08 1.34 1.55 -0.21 1.45 1.59 -0.14
3 1.45 1.45 0.00 1.31 1.56 -0.25 1.39 1.48 -0.09
4 1.16 1.43 -0.27 1.46 1.52 -0.06 1.28 1.47 -0.19
5 1.31 1.43 -0.12 1.64 1.54 0.10 1.44 1.47 -0.03
6 1.37 1.46 -0.09 1.32 1.52 -0.20 1.35 1.49 -0.14
7 1.44 1.40 0.04 1.60 1.53 0.07 1.50 1.45 0.05
8 1.49 1.52 -0.03 1.48 1.53 -0.05 1.49 1.54 -0.05
9 1.36 1.45 -0.09 1.46 1.53 -0.07 1.40 1.48 -0.08
10 1.49 1.52 -0.03 1.48 1.53 -0.05 1.49 1.54 -0.05
11 1.61 1.43 0.18 1.49 1.54 -0.05 1.56 1.47 0.09
12 1.57 1.51 0.06 1.62 1.60 0.02 1.59 1.52 0.07
13 1.15 1.42 -0.27 1.46 1.53 -0.07 1.27 1.46 -0.19
14 1.78 1.50 0.28 1.62 1.53 0.09 1.71 1.52 0.19
15 1.46 1.45 0.01 1.61 1.52 0.09 1.52 1.48 0.04
16 1.56 1.43 0.13 1.61 1.54 0.07 1.58 1.47 0.11
17 1.09 1.17 -0.08 1.48 1.40 0.08 1.24 1.27 -0.03
18 1.19 1.17 0.02 1.32 1.42 -0.10 1.24 1.27 -0.03
19 1.19 1.17 0.02 1.48 1.43 0.05 1.30 1.27 0.03
20 1.12 1.12 0.00 1.44 1.40 0.04 1.25 1.23 0.02
21 1.16 1.14 0.02 1.46 1.40 0.06 1.28 1.25 0.03
22 1.06 1.14 -0.08 1.31 1.42 -0.11 1.16 1.25 -0.09
23 1.22 1.19 0.03 1.19 1.40 -0.21 1.21 1.29 -0.08
24 1.22 1.19 0.03 1.49 1.43 0.06 1.33 1.29 0.04
25 1.40 1.26 0.14 1.38 1.40 -0.02 1.39 1.34 0.05
26 1.24 1.21 0.03 1.50 1.42 0.08 1.35 1.30 0.05








Fig. 2. Plot of observed pMIC
ab
 against predicted pMIC
ab 
by Eq 1.
Figure 3: Plot of observed pMIC
ab
 against residual pMIC
ab 
by Eq 1
LR-mt-QSAR model for antimicrobial activity 
 pMIC Te + 0.985am = −0 000115.  (3)





Figure 4: Plot of observed pMIC
am
 against predicted pMIC
am
by Eq 3.
Antimicrobial activity of the synthesized compounds was negatively 
correlated with total energy (Te) which means that antimicrobial activity of 
the synthesized compounds would increase with decrease in their Te values 
(Tables 2 and 4).
The total energy (Te) calculated by semi empirical methods can be used as 
a measure of non-specific interactions of a drug with its target site i.e. the total 
energies of the protonated and neutral forms of the molecule, can be considered 
as a good measure of the strength of hydrogen bonds (the higher the energy, 
the stronger the bond) and can be used to determine the correct localization of 
the most favorable hydrogen bond acceptor site (Narasimhan et al, 2009). 
The validity of QSAR model for antimicrobial activity (Eq. 3) was 
indicated by its high q2 value (0.540) as well as the low residual values (Table 




(Fig. 4) also 







indicated that there was
 
no systemic error 
in model development as the propagation of error was observed on both sides 
of zero (Kumar et al, 2007). The high residual values observed in case of 
outliers (1, 2, 3, 6 and 23, Table 7) justified their removal while developing 
QSAR models.
It was observed from mt-QSAR models [Eq. 1-3] that the antibacterial, 
antifungal and the overall antimicrobial activities of the synthesized PABA 
derivatives were governed by electronic parameters, total energy (Te) and 








Figure 5: Plot of observed pMIC
am




A series of Schiff bases (1-16) and ester (17-27) derivatives of p-amino benzoic 
acid (PABA) was synthesized and evaluated for its in vitro antimicrobial 
potential by using tube dilution method. In general, Schiff’s bases of PABA 
were found to be more potent than its esters.
Compound 11 was found to be most promising antibacterial agent. Further, 
QSAR studies were carried out to find correlation between antimicrobial activity 
and molecular descriptors of synthesized PABA derivatives which indicated 
the importance of electronic parameters total energy (Te) and energy of lowest 
unoccupied molecular orbital (LUMO) in describing the antimicrobial activity 
of synthesized compounds.
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